Get started
Author

Liam Smyth

Statin and cyclooxygenase‐2 inhibitors improve survival in newly diagnosed diffuse large B‐cell lymphoma: a large population‐based study of 4913 subjects
2020 · Liam Smyth, Danielle N. Blunt, et al. · British Journal of Haematology · 34
Can we reduce preventable heart failure readmissions in patients enrolled in a Disease Management Programme?
2009 · D. Phelan, L. Smyth, et al. · Irish Journal of Medical Science (1971 -) · 31
A Seizure Care Pathway in the Emergency Department: Preliminary Quality and Safety Improvements
2012 · Parameswaran M. Iyer, Patricia H. McNamara, et al. · Epilepsy Research and Treatment · 20
PDF
Shorter Diagnosis-to-Treatment Interval in Diffuse Large B-Cell Lymphoma is Associated With Inferior Overall Survival in a Large, Population-Based Registry
2021 · Danielle N. Blunt, Liam Smyth, et al. · Journal of the National Comprehensive Cancer Network · 15
Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ireland: A review of cases and current practices
2021 · D. Swan, H. Enright, et al. · Thrombosis Update · 7
PDF
Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study
2019 · Neil L Berinstein, Isabelle Bence-Bruckler, et al. · Blood · 7
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL
2017 · Niamh Appleby, David O’Brien, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Nonfamilial,MPLS505N-Mutated Essential Thrombocythaemia
2013 · Ruth Morrell, Stephen E. Langabeer, et al. · Case Reports in Hematology · 6
PDF
Autologous stem cell transplant and combination immunotherapy of rituximab and interferon‐α induces prolonged clinical and molecular remissions in patients with follicular lymphoma
2018 · Liam Smyth, Rena Buckstein, et al. · British Journal of Haematology · 4
Neuropsychological outcomes following HSCT in MS: A systematic review
2024 · Laura Davenport, Mathew McCauley, et al. · Multiple Sclerosis and Related Disorders · 3
Diagnosis to Treatment Interval in DLBCL Is Predictive of Overall Survival in a Large, Population-Based Registry
2018 · Danielle N. Blunt, Liam Smyth, et al. · Blood · 3
Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL
2015 · L. Smyth, P. V. Browne, et al. · Irish Journal of Medical Science (1971 -) · 3
Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive Disorder
2021 · Laura McDonald, Roseann O’ Doherty, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
MPL mutations are over-represented in patients with dual driver-mutated myeloproliferative neoplasms: an Irish cohort study
2026 · Laura Kearney, Claire Andrews, et al. · Hematology Transfusion and Cell Therapy · 1
PDF
Lymphoma Diagnostic Efficiency: Predictors for Diagnostic Delay and Prolonged Referral to Treatment Time
2023 · C. Jennings, K. Livingstone, et al. · Hematological Oncology · 1
PDF
Transient myeloproliferative disorder in an infant with PTPN 11 mutation
2017 · Andrea Malone, Marcin Wlodarski, et al. · British Journal of Haematology · 1
A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis
2024 · Laura Davenport, Mathew McCauley, et al. · Multiple Sclerosis and Related Disorders
Analysis of the Platelet Proteome Reveals Insights into the Pro-Inflammatory and Pro-Thrombotic State Associated with the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
2022 · Sarah Kelliher, Fionnuala Ní Áinle, et al. · Blood
Statins in mature B‐cell lymphomas and leukaemias
2021 · Liam Smyth, Danielle N. Blunt, et al. · British Journal of Haematology
PDF
Case Report: Discordant RT-PCR Results in COVID-19 Patient Challenges Clinical Decisions
2021 · Leila Smith, Liam Smyth, et al.
Predictors of Healthcare Utilization in Newly Diagnosed Myeloma
2020 · Shane Toolan, Mark Griffin, et al. · Blood
Statin and COX-2 Inhibitor Exposure Is Associated with Improved Survival in 4913 Newly Diagnosed DLBCL Patients: A Large Population Based Study
2019 · Liam Smyth, Danielle N. Blunt, et al. · Blood
SPIReL: PHASE 2 STUDY DPX‐SURVIVAC WITH INTERMITTENT LOW DOSE CYCLOPHOSPHAMIDE AND PEMBROLIZUMAB IN PATIENTS WITH RECURRENT/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
2019 · N.L. Berinstein, I.A. Bence‐Buckler, et al. · Hematological Oncology
Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α
2017 · Liam Smyth, Rena Buckstein, et al. · Blood
PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α
2017 · N. Berinstein, L. Smyth, et al. · Hematological Oncology
PDF
Works count: 25
Citation count: 145
H-index: 7
I10-index: 4
Year
Topic
Type